Your browser doesn't support javascript.
loading
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL.
Simonin, Mathieu; Lhermitte, Ludovic; Dourthe, Marie-Emilie; Lengliné, Etienne; Graux, Carlos; Grardel, Nathalie; Cayuela, Jean-Michel; Arnoux, Isabelle; Gandemer, Virginie; Ifrah, Norbert; Dombret, Hervé; Baruchel, André; Macintyre, Elizabeth; Petit, Arnaud; Boissel, Nicolas; Asnafi, Vahid.
Afiliação
  • Simonin M; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université de Paris, Paris, France.
  • Lhermitte L; Department of Pediatric Hematology and Oncology, AP-HP, Armand Trousseau Hospital, Sorbonne Université, Paris, France.
  • Dourthe ME; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France.
  • Lengliné E; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université de Paris, Paris, France.
  • Graux C; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France.
  • Grardel N; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université de Paris, Paris, France.
  • Cayuela JM; Institut Necker-Enfants Malades (INEM), INSERM U1151, Paris, France.
  • Arnoux I; Department of Pediatric Hematology and Immunology, Robert Debré Hospital, AP-HP, University Paris Diderot, Paris, France.
  • Gandemer V; Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France.
  • Ifrah N; Department of Hematology, Université Catholique de Louvain, CHU UCL Namur-site Godinne, Yvoir, Belgium.
  • Dombret H; Laboratory of Hematology, Centre Hospitalier Régional Universitaire (CHRU) Lille, Lille, France, and U1172, INSERM, Lille, France.
  • Baruchel A; Laboratory of Hematology and EA 3518 University Hospital Saint-Louis, AP-HP, Université de Paris.
  • Macintyre E; Hematology Laboratory, Marseille University Hospital Timone, Marseille, France.
  • Petit A; Department of Pediatric Hematology and Oncology, University Hospital of Rennes, Rennes, France.
  • Boissel N; PRES LUNAM (Pôle de Recherche et d'Enseignement Supérieur-l'Université Nantes Angers Le Mans), Centre Hospitalier Universitaire (CHU) Angers Service des Maladies du Sang, INSERM U892, Angers, France; and.
  • Asnafi V; Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France.
Blood ; 137(12): 1690-1694, 2021 03 25.
Article em En | MEDLINE | ID: mdl-33150353
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Transcrição Ikaros / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator de Transcrição Ikaros / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article